Verma A K
Department of Human Oncology, Univ. of Wisconsin, Clinical Cancer Center, Madison 53792.
Prog Clin Biol Res. 1988;259:245-60.
We have shown that retinoic acid, applied either to the skin or administered in diet, inhibits skin tumor promotion by TPA. Retinoic acid does not inhibit the initiation step of mouse skin carcinogenesis. Our results indicate that retinoic acid inhibits both stage I and stage II of tumor promotion, and the inhibition of tumor promotion depends upon the duration of retinoic acid treatment. The inhibition of skin carcinogenesis by retinoic acid is not universal; retinoids exhibit specificity towards carcinogens and tumor promoters. In conclusion, the results presented indicate that the inhibition of TPA-induced ODC gene expression may be one of the mechanisms contributing to the antitumor promoting property of the retinoids. However, other mechanisms concerning the effect of retinoic acid on chromatin structure (Porter et al., 1986), glycoprotein synthesis (Levin et al., 1983), peptide growth factors (Sporn et al., 1986), induction of transglutaminase (Lichti and Yuspa, 1985) and the host-immune system (Dennert, 1985) may also explain the molecular basis of retinoid action.
我们已经表明,无论是应用于皮肤还是通过饮食给予的视黄酸,都能抑制TPA对皮肤肿瘤的促进作用。视黄酸并不抑制小鼠皮肤致癌作用的起始步骤。我们的结果表明,视黄酸抑制肿瘤促进的I期和II期,并且肿瘤促进的抑制取决于视黄酸治疗的持续时间。视黄酸对皮肤致癌作用的抑制并非普遍存在;类维生素A对致癌物和肿瘤促进剂具有特异性。总之,所呈现的结果表明,抑制TPA诱导的ODC基因表达可能是类维生素A抗肿瘤促进特性的作用机制之一。然而,视黄酸对染色质结构(波特等人,1986年)、糖蛋白合成(莱文等人,1983年)、肽生长因子(斯波恩等人,1986年)、转谷氨酰胺酶的诱导(利希蒂和尤斯帕,1985年)以及宿主免疫系统(登纳特,1985年)的影响的其他机制也可能解释类维生素A作用的分子基础。